The investigators randomized 126 women to nitroglycerin ointment, 15 mg per day, applied at bedtime instead of every 6 to 8 hours, as it is prescribed for angina, and 117 women to placebo for 24 ...

Acrux Limited has announced the commercial launch of its Nitroglycerin 0.4% ointment in the US market through its licensee, TruPharma, following FDA approval.

PALO ALTO, Calif.-- (BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced preliminary top-line results from its two Phase 3 pivotal studies of Crisaborole Topical Ointment, 2 ...

Objective To produce a best evidence synthesis of the clinical effects of topical glyceryl trinitrate (GTN) in the treatment of tendinopathies. Design A systematic review of published randomised ...

Anacor Pharmaceuticals Announces FDA Acceptance of NDA for Crisaborole Topical Ointment, 2% for the Treatment of Mild-to-Moderate Atopic Dermatitis March 22, 2016 08:30 AM Eastern Daylight Time ...

Objectives To investigate if daily treatment with glyceryl trinitrate (GTN) ointment, over 24 weeks combined with a 12-week eccentric exercise programme is more effective for chronic mid-portion ...

Nature Reviews Gastroenterology & Hepatology - Is botulinum toxin injection a better treatment than nitroglycerin ointment for patients with chronic anal fissure?

Topical 0.1 percent tacrolimus ointment was applied twice daily to target lesions for patients in group A (excimer laser plus tacrolimus). Patients in group B received only the laser treatments.

Two formulations of novel topical isotretinoin ointment TMB-001 were associated with improvements over vehicle in congenital ichthyosis. TMB-001 0.05% showed slightly better clinical response than ...

Topical nitrates may be beneficial for patients with primary and secondary Raynaud’s phenomenon, according to a systematic review published in the Journal of the American Academy of Dermatology ...

Acrux Limited has announced the commercial launch of its Nitroglycerin 0.4% ointment in the US market through its licensee, TruPharma, following FDA approval. The company is also offering a Share ...